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Abstract
For more than a century, research on psychopathology has focused on categorical diagnoses. Although this work has 
produced major discoveries, growing evidence points to the superiority of a dimensional approach to the science 
of mental illness. Here we outline one such dimensional system—the Hierarchical Taxonomy of Psychopathology 
(HiTOP)—that is based on empirical patterns of co-occurrence among psychological symptoms. We highlight key 
ways in which this framework can advance mental-health research, and we provide some heuristics for using HiTOP 
to test theories of psychopathology. We then review emerging evidence that supports the value of a hierarchical, 
dimensional model of mental illness across diverse research areas in psychological science. These new data suggest 
that the HiTOP system has the potential to accelerate and improve research on mental-health problems as well as 
efforts to more effectively assess, prevent, and treat mental illness.
Keywords
mental illness, nosology, individual differences, transdiagnostic, Hierarchical Taxonomy of Psychopathology, HiTOP, 
ICD, DSM, RDoC
Dating back to Kraepelin and other early nosologists, 
research on psychopathology has been framed around 
mental disorder categories (e.g., What biological mal-
functions typify generalized anxiety disorder? How does 
antisocial personality disorder disrupt close relation-
ships?). This paradigm has produced valuable insights 
into the nature and origins of psychiatric problems. Yet 
there is now abundant evidence that categorical 
approaches to mental illness are hindering scientific 
progress. Grounded in decades of research, an alternate 
framework has emerged that characterizes psychopa-
thology using empirically derived dimensions that cut 
across the boundaries of traditional diagnoses. Recent 
efforts by a consortium of researchers to review and 
integrate findings relevant to this framework have given 
rise to a proposed consensus dimensional system, the 
Hierarchical Taxonomy of Psychopathology (HiTOP; 
Hierarchical Taxonomy of Psychopathology, 2018; 
Kotov et al., 2017).
Here, we first summarize the rationale behind dimen-
sional rubrics for mental illness and briefly sketch the 
topography of the HiTOP system (for detailed reviews, 
see Kotov et al., 2017; Krueger et al., 2018). Second, 
we explain how HiTOP can be used to improve research 
practices and theory testing. Third, we review new evi-
dence for the utility of HiTOP dimensions across vari-
ous research contexts, from developmental psychology 
to neuroscience. Finally, we offer some practical recom-
mendations for conducting HiTOP-informed research.
A Brief History of HiTOP
Mental illness is a leading burden on public-health 
resources and the global economy (DiLuca & Olesen, 
2014; Vos et al., 2016). Recent decades have witnessed 
the development of improved social science method-
ologies and powerful new tools for quantifying 
variation in the genome and brain, leading to initial 
optimism that psychopathology might be more readily 
explained and objectively defined (e.g., Hyman, 2007). 
Yet the billions of dollars spent on research have failed 
to yield much in the way of new cures, objective assays, 
or other major breakthroughs (Shackman & Fox, 2018).
A growing number of clinical practitioners and 
researchers—including the architects of the National 
Institute of Mental Health Research Domain Criteria 
(RDoC)—have concluded that this past underperfor-
mance reflects problems with categorical diagnoses 
rather than any intrinsic limitation of prevailing 
approaches to understanding risk factors and treat-
ment methods (Gordon & Redish, 2016). Categorical 
diagnoses—such as those codified in the Diagnostic 
and Statistical Manual of Mental Disorders (DSM) and 
the International Classification of Diseases (ICD)—
pose several well-documented barriers to discovering 
the nature and origins of psychopathology, including 
pervasive comorbidity, low symptom specificity, 
marked diagnostic heterogeneity, and poor reliability 
(Clark, Cuthbert, Lewis-Fernández, Narrow, & Reed, 
2017; Markon, Chmielewski, & Miller, 2011; Regier 
et  al., 2013). Regarding reliability, for instance, the 
field trials for the fifth edition of the DSM (DSM–5; 
American Psychiatric Association, 2013) found that 
approximately 40% of diagnoses examined did not 
reach the cutoff for acceptable interrater agreement 
(Regier et  al., 2013). Attesting to symptom-profile 
heterogeneity in the DSM, more than 600,000 symp-
tom presentations satisfy diagnostic criteria for post-
traumatic stress disorder (Galatzer-Levy & Bryant, 
2013).
Addressing these problems requires a fundamentally 
different approach. HiTOP—like other dimensional 
proposals such as RDoC (e.g., Brown & Barlow, 2009; 
Cuthbert & Insel, 2013)—focuses on continuously 
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distributed traits theorized to form the scaffolding for 
psychopathology. In the tradition of early factor analy-
ses of disorder signs and symptoms in adults (e.g., 
Eysenck, 1944; Lorr, Klett, & McNair, 1963; Tellegen, 
1985) and children (e.g., Achenbach, 1966; Achenbach, 
Howell, Quay, Conners, & Bates, 1991), a more recent 
quantitative analysis of psychological symptom co-
occurrence has established a reproducible set of dimen-
sions theorized to reflect the natural structure of 
psychological problems (Kotov et al., 2017).
Figure 1 provides a simplified schematic depiction 
of HiTOP, which features broad, heterogeneous con-
structs near the top of the model and specific, homo-
geneous dimensions near the bottom. HiTOP accounts 
for diagnostic comorbidity by positing dimensions (e.g., 
internalizing) that span multiple DSM diagnostic cat-
egories. It also models diagnostic heterogeneity by 
specifying fine-grain processes (e.g., worry, panic) that 
constitute the building blocks of mental illness. Indeed, 
profiles of narrow symptom dimensions (e.g., anhedonia, 
suicidality, situational fears) explain the variation on 
broad dimensions (e.g., elevated internalizing) in more 
detail.
HiTOP is an evolving model. An international group 
of researchers has assembled to investigate this struc-
ture and update it as new data emerge (Krueger et al., 
2018).1 (The HiTOP consortium publishes updates and 
revisions to the model on its website.) Indeed, the 
explicit goal of the HiTOP project is to follow the evi-
dence. The system is open for any type of revision that 
is supported by sufficient evidence; its core assumption 
is that a more valid nosology can be developed on the 
basis of the empirical pattern of clustering among psy-
chopathology phenotypes (i.e., symptoms and mal-
adaptive traits).
Refining this dimensional model is a key priority, but 
it is only one step in the evolution of HiTOP. Another 
key priority is to use HiTOP to improve and accelerate 
research focused on mental health and illness. As 
described in detail below, HiTOP has the potential to 
advance theories of psychopathology and make mental-
health research more efficient and informative.
HiTOP as a Psychopathology Research 
Framework
A distinguishing feature of HiTOP is its hierarchical 
organization (Fig. 1). Various processes—some specific, 
others quite broad—are potentially implicated in the 
origins and consequences of psychological problems 
across the life span (Forbes, Tackett, Markon, & Krueger, 
2016). The hierarchical structure implies that any cause 
or outcome of mental illness could emerge because of 
its effects on broad higher order dimensions, the 
syndromes, or specific lower order dimensions (Fig. 2). 
Take trauma, for example. Suppose that research based 
on the HiTOP framework establishes that trauma expo-
sure better predicts variation in the internalizing spec-
trum than in its constituent syndromes (e.g., depression, 
posttraumatic distress). How would this result change 
our conceptualization of this research area? It would 
call for an expansion of our etiological models of post-
traumatic distress to focus on the broad internalizing 
spectrum, including psychobiological processes shared 
by the mood and anxiety disorders. We might advise a 
moratorium on research studies that examine only one 
DSM disorder in relation to trauma exposure; instead, 
for maximum efficiency, we would simultaneously con-
sider various aspects of the internalizing spectrum (e.g., 
worry, rituals, insomnia, irritability) as outcomes in 
research studies. In addition, when making policy deci-
sions regarding prevention and intervention resources, 
we might prioritize screening trauma-exposed individu-
als for the full range of internalizing problems, not just 
posttraumatic stress disorder. In sum, thinking hierar-
chically about mental illness can promote more efficient 
research practices and more nuanced theory.
To illustrate these points, we now consider a more 
detailed example of putting HiTOP into practice (Fig. 3). 
For ease of presentation, DSM diagnoses constitute the 
basic units of assessment.2 A subset of HiTOP constructs 
are involved (listed in order of increasing granularity): 
the internalizing spectrum; fear, distress, and eating 
pathology subfactors; and their component syndromes 
(e.g., binge eating disorder, agoraphobia). These con-
structs serve as the predictor variables here.
For this example, we consider a test of an autonomic 
stress-reactivity theory of social phobia. The outcome 
of interest is skin-conductance level during an impromptu 
speech delivered to a group of impassive confederates. 
The researchers’ theory—which, like many others in 
psychopathology research, pertains to one particular 
categorical disorder—dictates that predictive path a in 
Figure 3 should eclipse the others: The social phobia 
diagnosis should be specifically associated with exag-
gerated autonomic reactivity in this evaluative social 
context. Alternatively, one could reasonably expect that 
excessive autonomic reactivity is a more general char-
acteristic of fear disorders (e.g., social phobia, panic 
disorder, agoraphobia) compared with distress or eating 
pathology syndromes. In that case, path b should sur-
pass the others in terms of variance explained. Finally, 
given evidence linking the full complement of anxiety 
and depressive disorders to stress responsivity, it is pos-
sible that reactivity is best captured at the spectrum 
level. In this last scenario, path c should predominate.
This heuristic illustrates that examining the validity 
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research strategy—is unnecessarily limiting. A zero-
order association between a DSM diagnosis and some 
outcome could reflect one (or more) qualitatively dis-
tinct pathways (in our example, paths a, b, or c in Fig. 
3). Hierarchical frameworks such as HiTOP provide a 
ready means of quantitatively comparing these alterna-
tives. If, in our example, the effect for path a is com-
paratively small, the research team will know to revise 
the autonomic arousal theory of social phobia to 
encompass fear-based or internalizing disorders more 
generally.
We supplement this case study with a real-world 
example of theory building driven by HiTOP. The stress-
generation theory posits that individuals with DSM-
diagnosed major depressive disorder encounter more 
stressful life events—including ones they have had a 
role in creating (e.g., romantic relationship dissolution, 
school expulsion)—than nondepressed counterparts 
(Hammen, 1991). Indeed, there is evidence that depres-
sion prospectively predicts stress exposure. However, 
more recent work suggests that this effect is not specific 
to depression. In fact, stress generation appears to be 
a general feature of the internalizing disorders and 
dispositional negativity (Liu & Alloy, 2010). Research 
from Conway, Hammen, and Brennan (2012), who 
demonstrated that the internalizing spectrum, external-
izing spectrum, and major depressive disorder all con-
tributed to the prediction of future stress exposure 
when considered simultaneously, is consistent with this 
hypothesis (see Fig. 3; Conway et al., 2012). Note that 
panic disorder had an inverse effect on stress occur-
rence after adjusting for the transdiagnostic dimen-
sions. The authors labeled this novel association a 
“stress-inhibition” effect.
These findings prompted a reformulation of stress-
generation theory. First, stress-generation processes are 
now hypothesized to operate across a range of internal-
izing and externalizing syndromes, not just major 
depressive disorder. Second, the HiTOP-consistent 
analysis pointed to a role for depression-specific pathol-
ogy in predicting stressful events above and beyond 
the effects of the internalizing spectrum (i.e., incremen-
tal validity). Theorists can use that result to consider 






























Fig. 2. Conceptual diagrams of three possible HiTOP research designs. The diagrams show comparisons of the predictive validity (a) across 
HiTOP levels, (b) within HiTOP levels, and (c) of categorical diagnoses to HiTOP dimensions. BPD = bipolar disorder; DSM = Diagnostic and 
Statistical Manual of Mental Disorders; HiTOP = Hierarchical Taxonomy of Psychopathology; ICD = International Classification of Diseases; 
MDD = major depressive disorder; OSDD = other specified depressive disorder; PDD = persistent depressive disorder.
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increase the likelihood of encountering significant 
stressors. Third, this work highlights the need to under-
stand more fully the stress-inhibiting consequences of 
panic symptoms, a signal that was not detectable when 
analyzing DSM diagnoses only.
Up to this point, we have considered how a hierarchical 
approach—that is, comparing pathways to and from 
dimensions at different levels of HiTOP—can advance 
our understanding of psychopathology. Although this 
approach has been the most common application of 
HiTOP, it is not the only one. Some researchers have 
used HiTOP to dissect DSM diagnoses into components 
and compare their criterion validity (e.g., Simms, Grös, 
Watson, & O’Hara, 2008; Fig. 2b). For example, panic 
disorder could be decomposed into physiological (e.g., 
tachycardia, choking sensations) and psychological 
(e.g., thoughts of dying or going crazy) symptoms. The 
predictive validity of these two symptom domains could 
then be compared in relation to a clinical outcome of 
interest (e.g., emergency-room visits). Other researchers 
have evaluated the joint predictive power of sets of 
HiTOP dimensions above and beyond the correspond-
ing DSM–5 diagnosis (see Waszczuk, Kotov, Ruggero, 
Gamez, & Watson, 2017; Waszczuk, Zimmerman, et al., 
2017). This approach explicitly compares the explana-
tory potential of dimensional versus categorical 
approaches to psychopathology (Fig. 2c).
Investigators are beginning to use these research 
strategies to reevaluate existing theories and findings 
through a HiTOP lens. In the sections that follow, we 
describe studies that have approached etiological and 
clinical outcome research from a HiTOP perspective as 
a way of selectively illustrating its utility.
Etiological Research From a HiTOP 
Perspective
Quantitative and molecular genetics
Twin studies find that HiTOP dimensions often are 
underpinned by distinct genetic liability factors, sug-
gesting that the phenotypic and genetic structures of 
psychopathology may be closely aligned (e.g., Lahey, 
Krueger, Rathouz, Waldman, & Zald, 2017; Røysamb 
et al., 2011). For example, twin research has documented 
an overarching genetic liability factor that resembles a 
general factor of psychopathology (Pettersson, Larsson, 
& Lichtenstein, 2016). This general factor (see the top 
level of Fig. 1) was first described in phenotypic analy-
ses (Lahey et  al., 2012) and later was termed the “p 
factor” as a counterpart to the g factor in the intelli-
gence literature (Caspi et  al., 2014; Caspi & Moffitt, 
2018). Consistent with the broad intercorrelations 
among higher order spectra in psychometric studies, 
there is growing evidence that common genetic vulner-
abilities underlie a general (i.e., transdiagnostic) risk 
for psychopathology (Selzam, Coleman, Moffitt, Caspi, 
& Plomin, 2018; Waszczuk, 2018).
At a lower level of the hierarchy, genetic influences 
operating at the spectrum level have also been identified. 
For example, anxiety and depressive disorders seem to 
substantially share a common genetic diathesis, whereas 
antisocial behavior and substance-use conditions share 
a distinct substrate (Kendler & Myers, 2014). There is also 
a consistent but underdeveloped line of twin research 
that provides biometric support for the genetic coherence 



























Fig. 3. Heuristic model of the internalizing domain in relation to autonomic reactivity to a laboratory challenge. Paths a, b, and c repre-
sent regressions of the outcome on dimensions at different levels of the hierarchical model. GAD = generalized anxiety disorder; MDD = 
major depressive disorder; OCD = obsessive-compulsive disorder; PTSD = posttraumatic stress disorder; SAD = separation anxiety disorder.
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Jang, & Vernon, 1998; Tarbox & Pogue-Geile, 2011). Fur-
ther attesting to the hierarchical structure of genetic risk, 
distinct genetic influences have been identified for the 
distress and fear subfactors of the internalizing spectrum 
(Waszczuk, Zavos, Gregory, & Eley, 2014). Finally, twin 
research shows that narrow psychiatric syndromes—and 
even certain symptom components within them—might 
possess unique genetic underpinnings alongside the 
genetic vulnerability shared with other psychiatric condi-
tions more broadly (e.g., Kendler, Aggen, & Neale, 2013; 
Rosenström et al., 2017). Overall, although these specific 
genetic factors are often comparatively small, they pro-
vide etiological support for a hierarchical conceptualiza-
tion of psychopathology. A key challenge for future 
researchers will be to evaluate more comprehensive ver-
sions of the HiTOP model in adequately powered, geneti-
cally informative samples (e.g., twin, genome-wide 
association studies, or GWASs).
Emerging cross-disorder molecular genetic studies 
also suggest that genetic influences operate across diag-
nostic boundaries (Smoller et al., 2018). For example, a 
recent meta-analysis of GWASs of DSM-diagnosed gen-
eralized anxiety disorder, panic, agoraphobia, social 
anxiety, and specific phobia identified common variants 
associated with a higher order anxiety factor, consistent 
with the HiTOP fear subfactor (Otowa et al., 2016). Other 
work reveals moderate (38%) single-nucleotide polymor-
phism (SNP)-based heritability of the p factor, indicating 
that common SNPs are associated with a general psy-
chopathology factor in childhood (Neumann et  al., 
2016). Beyond these broader spectra, several molecular 
genetic studies have focused on constructs at the subor-
dinate level of the HiTOP hierarchy, partly to reduce 
phenotypic heterogeneity and amplify genetic signals. 
For example, one GWAS investigated a narrowly defined 
phenotype of mood instability, which led to a discovery 
of four new genetic variants implicated in mood disor-
ders (Ward et al., 2017). Together, these emerging results 
suggest that it will be possible to identify specific genetic 
variants at different levels of the HiTOP hierarchy, with 
some influencing nonspecific psychopathology risk and 
others conferring risk for individual spectra, subfactors, 
or even symptoms (e.g., anhedonia). In contrast, tradi-
tional case-control designs and even studies focused on 
pairs of disorders are incapable of untangling such hier-
archical effects. In short, HiTOP promises to provide a 
more effective framework for discovering the genetic 
underpinnings of mental illness, although further empiri-
cal evidence and replications of any specific molecular 
genetic findings are, of course, needed.
Neurobiology
Paralleling the genetics literature, growing evidence 
shows that many measures of brain structure and 
function do not conform to the boundaries implied by 
traditional DSM/ICD diagnoses. There are no clear-cut 
depression or schizophrenia “centers” in the brain (e.g., 
Sprooten et  al., 2017). Instead, associations between 
the brain and mental illness often show one-to-many 
or many-to-many relations (i.e., multifinality; Zald & 
Lahey, 2017). Heightened amygdala reactivity, for exam-
ple, has been shown to confer risk for the future emer-
gence of mood and anxiety symptoms, posttraumatic 
distress, and alcohol abuse (e.g., McLaughlin et  al., 
2014; Swartz, Knodt, Radtke, & Hariri, 2015). The inter-
nalizing and externalizing spectra are both associated 
with altered maturation of subcortical structures in late 
childhood (Muetzel et al., 2018). In some cases, these 
relations have been shown to reflect specific symptoms 
that cut across the categorical diagnoses outlined in the 
DSM. For instance, anhedonia is a central feature of 
both mood and thought disorders in the DSM, and 
dimensional measures of anhedonia have been linked 
to aberrant ventral striatum function (i.e., activity and 
functional connectivity) in several large-scale, mixed-
diagnosis studies (Sharma et al., 2017; Stringaris et al., 
2015).
Evidence of one-to-many relations is not limited to 
the neuroimaging literature. The P3 event-related 
potential, for example, has been linked to a variety of 
externalizing disorders and to dimensional measures of 
externalizing (Iacono, Malone, & McGue, 2003; Patrick 
et  al., 2006). Cross-sectional and prospective studies 
have linked the error-related negativity to a variety of 
DSM-diagnosed anxiety disorders, to the development 
of internalizing symptoms, and to dimensional mea-
sures of anxiety (Cavanagh & Shackman, 2015; Meyer, 
2017).
Although the neural bases of the p factor remain far 
from clear, recent neuroimaging research has begun to 
reveal some neural systems with conspicuously similar 
(i.e., transdiagnostic) features. In a recent meta-analysis, 
McTeague and colleagues (2017) identified a pattern of 
aberrant activation shared by the major mental disorders. 
When performing standard cognitive control tasks (e.g., 
go/no-go, Stroop), patients diagnosed with DSM-
diagnosed anxiety disorders, bipolar disorder, depres-
sion, schizophrenia, or substance abuse all exhibited 
reduced activation in parts of the so-called salience net-
work, including regions of the cingulate, insular, and 
prefrontal cortices. Applying a similar approach to voxel-
by-voxel measures of brain structure, Goodkind and col-
leagues (2015) identified a neighboring set of regions in 
the midcingulate and insular cortices showing a common 
pattern of cortical atrophy across patients diagnosed with 
a range of DSM-diagnosed disorders (anxiety, bipolar 
disorder, depression, obsessive-compulsive, and schizo-
phrenia). Few disorder-specific effects were detected in 
either of these large meta-analyses.
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More recent imaging research has begun to adopt 
the kinds of analytic tools widely used in psychometric 
and genetic studies of psychopathology, enabling a 
direct comparison of different levels of HiTOP (see Fig. 
2a) and new clues about the neural bases of the p fac-
tor. Using data acquired from the Philadelphia Neuro-
developmental Cohort, Shanmugan and colleagues 
(2016) identified the p factor and four nested subdimen-
sions (antisocial behavior, distress, fear, and psychosis; 
see Fig. 1, subfactor level). Higher levels of the p factor 
were associated with reduced activation and aberrant 
multivoxel patterns of activity in the salience network 
(cingulate and insular cortices) during the performance 
of the n-back task, a widely used measure of working 
memory capacity and executive function. After account-
ing for the phenotypic variance explained by the 
p factor, the antisocial, distress, and psychosis dimen-
sions were each associated with additional subfactor-
specific alterations in task-evoked activation (e.g., 
psychosis was uniquely associated with hypoactivation 
of the dorsolateral prefrontal cortex). Using the same 
sample, Kaczkurkin et al. (2018) found an analogous 
pattern of results with measures of resting activity. 
These observations converge with the meta-analytic 
results discussed above (Goodkind et al., 2015; McTeague 
et al., 2017) and reinforce the idea that a circuit cen-
tered on the cingulate cortex underlies a range of com-
mon psychiatric symptoms and syndromes. Still, it is 
implausible that this circuit will completely explain a 
phenotype as broad as the p factor. Indeed, other cor-
relates are rapidly emerging (Romer et al., 2018; Sato 
et al., 2016; Snyder, Hankin, Sandman, Head, & Davis, 
2017).
Collectively, these results highlight the value of the 
HiTOP framework for organizing neuroscience and 
other kinds of biological research. Adopting a hierarchi-
cal, dimensional approach makes it possible to dissect 
brain structure and function quantitatively, facilitating 
the discovery of features that are common to many or 
all of the common mental disorders, those that are 
particular to specific spectra and syndromes, and those 
that underlie key transdiagnostic symptoms—a level of 
insight not afforded by RDoC or traditional diagnosis-
centered nosologies.
Environmental risk
Stressful environments are intimately intertwined with 
risk for mental illness. For decades, researchers have 
proposed theories about the connections between 
stressors and specific diagnoses (e.g., loss, DSM-
diagnosed major depressive disorder). Yet it is clear 
that most stressors are nonspecific and confer increased 
risk for diverse psychopathologies (McLaughlin, 2016). 
Socioeconomic adversity, discrimination, harsh parent-
ing, bullying, and trauma all increase the likelihood of 
developing psychiatric illness (Caspi & Moffitt, 2018; 
Lehavot & Simoni, 2011; Wiggins, Mitchell, Hyde, & 
Monk, 2015). This lack of specificity raises the possibil-
ity that many stressors act on illness processes that are 
shared across entire subfactors (e.g., distress, antisocial 
behavior), spectra (e.g., internalizing), or even super-
spectra. Investigators can use HiTOP to identify the 
level or levels at which stressful environments exert 
their effects.
Childhood maltreatment represents an instructive 
case because it has potent and nonspecific relations 
with future psychopathology (Green et al., 2010). Sev-
eral studies have used a hierarchical approach to assess 
the relative importance of higher order (i.e., transdiag-
nostic) versus diagnosis-specific pathways from early 
maltreatment to mental disorders in adulthood. Leverag-
ing interview-based diagnoses and retrospective reports 
of childhood maltreatment collected as part of the 
National Epidemiological Survey on Alcohol and 
Related Conditions (NESARC; n > 34,000), Keyes et al. 
(2012) observed strong relations between childhood 
maltreatment and the internalizing and externalizing 
spectra (see path c in Fig. 3) but not specific diagnoses 
(see path a in Fig. 3). In other words, the marked 
impact of childhood maltreatment on adult psychopa-
thology was fully mediated by the transdiagnostic spec-
tra. Similar findings emerged in a community sample 
of more than 2,000 youth enriched for exposure to 
maltreatment (Vachon, Krueger, Rogosch, & Cicchetti, 
2015; see also Conway, Raposa, Hammen, & Brennan, 
2018; Lahey et al., 2012; Meyers et al., 2015; Sunderland 
et al., 2016).
The HiTOP framework has also been used to under-
stand the influence of chronic stressors in adulthood 
(Snyder, Young, & Hankin, 2017). For instance, 
Rodriguez-Seijas, Stohl, Hasin, and Eaton (2015) recently 
showed that racial discrimination has strong associa-
tions with the internalizing and externalizing spectra 
(see path c in Fig. 3) in a nationally representative 
sample of more than 5,000 African Americans. For most 
disorders, the pathway from discrimination to particular 
DSM diagnoses (e.g., attention-deficit/hyperactivity dis-
order, social phobia) was largely explained by its 
impact on higher-order spectra. In a few cases, discrimi-
nation was directly associated with specific diagnoses 
(e.g., alcohol use disorder). These effects make it clear 
that multiple pathways from environmental adversity 
to psychopathology are possible—some centered on 
transdiagnostic spectra and others on more specific 
syndromes—with important implications for efforts to 
develop more effective and efficient strategies for pre-
venting and treating mental illness.
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Clinical Outcome Research From a 
HiTOP Perspective
Like etiological factors, clinical outcomes often reflect 
a mixture of specific and transdiagnostic effects and, 
as a result, are better aligned with HiTOP than tradi-
tional diagnostic systems such as DSM or ICD.
Prognosis
Clinicians and researchers often seek to forecast the 
onset or recurrence of psychological problems on the 
basis of diagnostic and symptom data (e.g., Morey 
et  al., 2012). The HiTOP system has the potential to 
streamline this prognostic decision making. For instance, 
using data gleaned from the World Mental Health Sur-
veys (N > 20,000), Kessler, Petukhova, and Zaslavsky 
(2011) examined the prognostic value of 18 disorders 
from the fourth edition of the DSM (DSM–IV; American 
Psychiatric Association, 1994) in predicting new onsets 
of subsequent diagnoses. They found that the vast 
majority of the development of categorical diagnoses 
arising at later time points was attributable to variation 
on internalizing and externalizing dimensions earlier 
in life (for similar results, see Eaton et al., 2013). This 
result suggests that higher-order dimensions can often 
provide a more efficient means of predicting the natural 
course of mental illness (see also Kotov, Perlman, 
Gámez, & Watson, 2015; Olino et al., 2018).
Suicide
The HiTOP framework has also proven useful for opti-
mizing suicide prediction. Tools for forecasting suicide 
are often based on the presence or absence of specific 
diagnoses (e.g., bipolar disorder, borderline personality 
disorder). However, recent large-scale studies have con-
sistently shown that the predictive power of DSM diag-
noses pales in comparison to that of higher order 
dimensions. For instance, in the NESARC sample 
described earlier, the distress subfactor (Fig. 1) explained 
approximately 34% of the variance in suicide attempt 
history. In contrast, the top-performing DSM diagnoses 
accounted for only approximately 1% (Eaton et al., 2013; 
see also Naragon-Gainey & Watson, 2011; Sunderland 
& Slade, 2015). These kinds of observations indicate that 
suicide risk is better conceptualized at the level of spec-
tra, not syndromes, contrary to standard research and 
clinical practices.
Impairment
Psychosocial impairment is typically a core feature of 
contemporary definitions of psychopathology, and it 
often persists long after acute symptoms have abated. 
Understanding impairment is important for prioritizing 
scarce resources. But is impairment better explained 
and, more importantly, predicted by DSM/ICD diagno-
ses or transdiagnostic dimensions? Using data from the 
Collaborative Longitudinal Personality Disorders Study 
(N = 668), Morey et al. (2012) found that maladaptive 
personality traits were twice as effective at predicting 
patients’ functional impairment across a decade-long 
follow-up compared with traditional diagnoses (see Fig. 
2c). Likewise, Forbush et al. (2017) demonstrated that 
higher order dimensions explained 68% of the variance 
in impairment in a sample of patients with an eating 
disorder. In contrast, anxiety, depression, and eating 
disorder diagnoses collectively explained only 11%. In 
the area of psychosis, van Os and colleagues (1999) 
compared the predictive power of five dimensions ver-
sus eight DSM diagnoses in a large longitudinal sample 
across 20 distinct psychosocial outcomes (e.g., disabil-
ity, unemployment, cognitive impairment, suicide). For 
every outcome with a clear difference in predictive 
validity, dimensions outperformed diagnoses.
Waszczuk, Kotov, et al. (2017) reported similar results 
in two samples evaluated with the Interview for Mood 
and Anxiety Symptoms (IMAS), which assesses the 
lower order components of emotional pathology (e.g., 
lassitude, obsessions). These dimensions explained 
nearly two times more variance in functional impair-
ment than did DSM diagnoses. Moreover, DSM diagno-
ses did not show any incremental predictive power over 
the dimensional scores—a particularly striking result 
given that impairment is part of the DSM diagnostic 
criteria but not directly captured by IMAS scores (see 
Fig. 2c). In sum, this line of research suggests that 
transdiagnostic dimensions of the kinds embodied in 
HiTOP have superior prognostic value—both concur-
rently and prospectively—for psychosocial impairment 
(see also Jonas & Markon, 2013; Markon, 2010; South, 
Krueger, & Iacono, 2011).
Summary
Theoretical models of the causes and consequences of 
psychiatric problems have traditionally been framed 
around diagnoses. New research highlights the impor-
tance of extending this focus to encompass transdiag-
nostic dimensions, including both narrowly defined 
symptoms and traits (e.g., obsessions) and broader 
clusters of psychological conditions (e.g., internalizing 
spectrum). In contrast to other classification systems 
(e.g., DSM) and unlike RDoC, HiTOP provides a con-
venient framework for directly testing the relative 
importance of symptom components, syndromes, spec-
tra, and superspectra (e.g., p factor) for the emergence 
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and treatment of psychopathology (Fig. 1). The evidence 
reviewed here suggests that in many cases mental illness 
is better conceptualized in terms of transdiagnostic 
dimensions.
HiTOP: A Practical Guide
A primary objective of this review is to provide inves-
tigators with some practical recommendations for incor-
porating HiTOP into their research. Here we outline 
design, assessment, and analytic strategies that follow 
from the theory and available data underpinning HiTOP.
Design
The lion’s share of clinical research has historically 
been conducted using traditional case-control designs, 
in which participants meeting criteria for a particular 
diagnosis are compared with a group free of that dis-
order or perhaps any mental illness. This approach is 
generally inconsistent with a dimensional perspective 
on psychopathology. There is compelling evidence that 
mental illness is continuously distributed in the popula-
tion, without the gaps or “zones of discontinuity” 
expected of categorical illnesses (Krueger et al., 2018; 
for a different perspective, see Borsboom et al., 2016). 
These observations indicate that artificially separating 
case subjects from non-case subjects leads to an appre-
ciable loss of information (Markon et al., 2011), consis-
tent with more general recommendations to avoid post 
hoc dichotomization (e.g., median splits) of continuous 
constructs (Preacher, Rucker, MacCallum, & Nicewander, 
2005).
The case-control strategy also ignores the issue of 
diagnostic comorbidity. The ubiquitous co-occurrence 
of disorders makes it extremely difficult to establish 
discriminant validity for most categorical syndromes. 
In practical terms, any distinction between, say, patients 
with panic disorder and healthy controls in a particular 
study may not be a unique characteristic of panic dis-
order. It could instead reflect the influence of a higher 
order dimension, such as the HiTOP fear subfactor, that 
permeates multiple diagnoses (e.g., panic disorder, ago-
raphobia, social anxiety disorder, and specific phobia). 
By disregarding the symptom overlap among clusters 
of related conditions, the case-control design is bound 
to underestimate the breadth of psychopathology asso-
ciated with a given clinical outcome.
From an efficiency standpoint, recruiting on the basis 
of particular diagnoses creates a fragmented scientific 
record. The traditional approach of studying one dis-
order in relation to one outcome has spawned many 
insular journals, societies, and scholarly subcommuni-
ties (“silos”). This convention belies the commonalities 
among disorders and has led to piecemeal progress. 
For example, the initial phases of psychiatric genetic 
research were oriented around specific diagnoses. 
There were separate studies focused on the molecular 
genetic origins of obsessive-compulsive disorder, gen-
eralized anxiety disorder, posttraumatic stress disorder, 
and so on. Analogously, the research on childhood 
maltreatment in relation to various individual syn-
dromes is voluminous. These lines of research have 
consumed considerable resources but have revealed 
few (if any) replicable one-to-one associations between 
risks and disorders. A more parsimonious and efficient 
approach is to recruit participants on the basis of a 
particular psychopathological dimension (e.g., antiso-
cial behavior, excitement seeking), either sampling to 
ensure adequate representation of all ranges of this 
dimension or recruiting at random from the population 
of interest (e.g., community, students, outpatients) to 
provide a representative sample.3 Then, as was the case 
for our fictional study of autonomic disruptions in 
social phobia, the effects of both general and more 
specific dimensions of psychopathology can be com-
pared empirically. Thinking broadly, such a strategy 
promises to facilitate more cumulative, rapid progress 
in developing etiological models for a wide range of 
psychological conditions.
It is worth noting that some of these recommenda-
tions can be addressed after the fact. Many of the analy-
ses that we have reviewed in earlier sections were 
carried out using data sets that were not assembled with 
HiTOP in mind. However, these projects have generally 
included a thorough assessment of psychopathology 
outcomes, which can serve as building blocks for quan-
titative investigations of symptom or syndrome co-
occurrence via factor analysis or related techniques. For 
example, there have been several studies of the cor-
relates (e.g., demographic features, environmental 
stressors) of higher order dimensions versus syndromes 
in epidemiological studies, such as the National Comor-
bidity Survey Replication and NESARC (e.g., Eaton 
et al., 2013; Keyes et al., 2012; Slade, 2007). Investiga-
tors have also taken advantage of comprehensive psy-
chopathology assessments in longitudinal cohort 
studies—such as the Dunedin Multidisciplinary Health 
and Development Study and the Pittsburgh Girls 
Study—to examine the temporal course and longitudi-
nal correlates of HiTOP dimensions (e.g., Krueger, 
Caspi, Moffitt, & Silva, 1998; Lahey et al., 2015; McElroy 
et al., 2018). These cohort studies are particularly valu-
able for theory building because they tend to have rich 
assessments of validators (etiological factors, clinical 
outcomes; e.g., Caspi et al., 2014).
Studies do not need to have especially large samples 
or wide-ranging assessment batteries (e.g., “big data”) 
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to take advantage of the HiTOP framework. Often, 
dimensional measures of psychopathology can be inte-
grated into typical (in terms of resources and sample 
size) study designs. Take, for example, the fictional 
study of autonomic reactivity described earlier. We 
described a scenario in which diagnoses were the basic 
units of mental illness and were used to infer standing 
on the next higher level dimensions (i.e., the subfactor 
and spectrum levels). However, analogous tests could 
be carried out if researchers administered a self-report 
questionnaire assessing both the broad and specific 
features of the internalizing domain, such as the Inven-
tory of Depression and Anxiety Symptoms (Watson 
et  al., 2012). For instance, the effect of lower order 
symptom components (e.g., lassitude, obsessions; see 
Fig. 3 path c) on autonomic reactivity could be com-
pared with the effect of a higher level (e.g., spectrum) 
dimension (e.g., dysphoria; see Fig. 3 path a). We 
expect that, in most research situations, moderately 
sized samples would suffice to precisely gauge these 
effects. More generally, we expect that empirically 
derived dimensional measures of mental illness can 
be integrated effectively into most standard research 
designs. Along those lines, we plan to publish a 
series of “worked examples” on the HiTOP consor-
tium website that illustrate the methodological and 
data-analytic steps—including relevant materials, 
data, and code—in typical studies that apply the 
HiTOP framework.
Assessment
Although assessing multiple syndromic or symptom 
constructs in the same study represents an improvement 
over “one disorder, one outcome” designs, this approach 
has limitations. DSM/ICD diagnoses and many symptom 
measures are notoriously heterogeneous, meaning they 
are composed of multiple lower order dimensions of 
psychopathology. For instance, many common depres-
sive symptom scales include not only cognitive and 
vegetative symptoms, which arguably have separate 
etiologies and correlates, but also anxiety symptoms 
(e.g., Fried, 2017). Thus, a more optimal approach is 
to forego traditional diagnostic constructs in favor of 
assessing lower order dimensions of pathology (e.g., 
the symptom component level of Fig. 1). This strategy 
maximizes the precision of the dimensions that can be 
examined, improving our ability to “carve nature at its 
joints.”
Consequently, we recommend using assessment 
instruments that measure both higher and lower order 
dimensions of psychopathology. A number of such 
measures are reviewed in Kotov et al. (2017). No omni-
bus inventory yet exists that covers the entirety of the 
HiTOP framework, although our consortium is currently 
developing one. Instead, many existing measures assess 
specific aspects (e.g., component/trait, syndrome, and 
subfactor levels) of the HiTOP model (see https://
psychology.unt.edu/hitop). Researchers can use these 
measures to perform a complete assessment of one 
spectrum (e.g., antagonistic externalizing) or several 
(e.g., antagonistic externalizing, disinhibited external-
izing, thought disorder). The list of measures is expected 
to continue evolving, and researchers can refer to the 
HiTOP website to access the latest inventories, includ-
ing a forthcoming comprehensive measure of the full 
HiTOP model as currently constituted. Most facets of 
the HiTOP structure can currently be assessed economi-
cally with questionnaire measures that are available in 
self- and informant-report versions. Structured and 
semistructured interview approaches can also be used, 
assuming they allow for dimensional scoring. Of course, 
for such assessments to be compatible with HiTOP, they 
may need to be modified to eliminate “skip rules” (e.g., 
if neither significant depressed mood or anhedonia is 
endorsed, some interview procedures automatically exit 
the major depression section) and hierarchical decision 
rules (e.g., DSM–IV stipulated that generalized anxiety 
disorder could not be diagnosed if it presented only in 
the context of a co-occurring depressive disorder) to 
collect all symptom data. Overriding these rules permits 
an assessment of the full clinical picture.
Analysis
There are several different ways for investigators to test 
the association of dimensional constructs with out-
comes of interest. Expertise with latent variable model-
ing is not a prerequisite. Many popular measurement 
tools (e.g., the Child Behavior Checklist; Achenbach, 
1991) include a combination of broad (e.g., external-
izing) and narrow (e.g., aggression) dimensions. Con-
nections of these scales with background characteristics 
or clinical outcomes could then be contrasted using 
standard regression approaches.
In the case of large samples, it is possible to use 
latent variable modeling to empirically extract the rel-
evant dimensions. Exploratory factor analysis (EFA) is 
an atheoretical approach to determining the appropri-
ate number and nature of latent dimensions undergird-
ing psychological problems. In many common statistical 
packages, it is possible to perform an EFA and then 
extract factor scores—values that represent a person’s 
standing on a latent dimension—that can be used as 
variables in standard regression or analysis of variance 
procedures (although this procedure has some draw-
backs; e.g., Devlieger, Mayer, & Rosseel, 2016). Confir-
matory factor analysis, a hypothesis-driven approach 
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in which the researcher specifies the relations of symp-
tom or diagnostic constructs to latent dimensions, is 
another common approach. Finally, using a series of 
factor analyses to explicate a hierarchical factor structure 
by proceeding from higher (broader) to lower (narrower) 
levels of specificity (termed the “bass-ackwards” method) 
can be useful in extracting HiTOP dimensions from 
symptom- or diagnostic-level data (see Goldberg, 2006).
Future Challenges
There are clear and compelling scientific reasons to 
adopt HiTOP-style approaches to understanding psy-
chopathology, but it is equally clear that additional 
work will be required to refine this framework and 
determine its optimal role in mental illness research. 
Uncertainties regarding several architectural elements 
of HiTOP remain. Additional research is needed to 
incorporate psychiatric problems not currently included 
in HiTOP (e.g., autism spectrum disorder and other 
neurodevelopmental conditions) and to validate the 
placement of domains of psychopathology that have 
received limited attention in structural studies (e.g., 
lower order dimensions of mania as components of 
internalizing versus thought disorder). At the spectrum 
level, data are particularly limited for HiTOP’s somato-
form and detachment dimensions. Further, continued 
research is needed on possible latent taxa, as opposed 
to dimensions, involved in mental illness. Taxometric 
research has favored dimensions over categories for 
every HiTOP construct that has been examined to date; 
however, in theory, zones of discontinuity could emerge 
and would therefore merit inclusion in the HiTOP 
model. For example, deviation on multiple dimensions 
may yield discontinuous cutoffs (cf. Kim & Eaton, 2017). 
In short, the HiTOP framework is a work in progress, 
and researchers are encouraged to consult the consor-
tium website for updates or to apply for membership 
in the consortium and contribute to improving the 
model.
Moving forward, we also need to carefully examine 
the use and interpretation of factor analysis with respect 
to HiTOP. There are questions about whether the theo-
retical constructs outlined in HiTOP satisfy assumptions 
of the common factor model (e.g., van Bork, Epskamp, 
Rhemtulla, Borsboom, & van der Maas, 2017; see also 
Borsboom, Mellenbergh, & Van Heerden, 2003). For 
instance, are the factors (e.g., fear, detachment) natu-
rally occurring phenomena that directly cause variation 
in their indicators (e.g., panic, social phobia)? Or are 
the HiTOP factors simply useful—and, to some extent, 
artificial—summaries of symptom covariation (see Jonas 
& Markon, 2016)? We note that although factor analysis 
has proved to be a useful tool in this area of research, 
HiTOP outcomes need not be represented by latent 
variables; it is possible to operationalize them directly 
using questionnaire and interview measures of the 
types mentioned earlier, although every specific mea-
sure has strengths, weakness, and a particular range of 
applicability, so it will be important not to equate mea-
sures with constructs.
Additional work will also be required to better 
understand the degree to which HiTOP is compatible 
with network models and the RDoC framework (e.g., 
Clark et al., 2017; Fried & Cramer, 2017). Network mod-
els conventionally assume that psychopathology does 
not reflect latent traits; psychological syndromes instead 
arise from a chain reaction of symptoms activating one 
another (e.g., Cramer, Waldorp, van der Maas, & Borsboom, 
2010). A common example is that a constellation of 
depression symptoms might coalesce not because of 
the guiding influence of an unobserved, unitary depres-
sion dimension but rather because of a snowballing 
sequence of symptom development (e.g., insomnia → 
fatigue, fatigue → concentration problems). The pur-
pose of the network model is to discern these hypoth-
esized causal pathways among symptoms. In contrast, 
HiTOP aims to identify replicable clusters of symptoms 
that have shared risk factors and outcomes. Both per-
spectives can be useful for understanding the nature of 
psychopathology and are not necessarily mutually 
exclusive (e.g., Fried & Cramer, 2017).
Like HiTOP, the National Institute of Mental Health’s 
RDoC initiative deconstructs psychopathology into 
more basic units that cut across traditional diagnoses 
(Table 1). However, its primary focus is on fundamental 
biobehavioral processes (e.g., reward, anxiety), espe-
cially those conserved across species, that are disrupted 
in mental illness (Clark et al., 2017). This approach has 
gained traction in biological psychology and psychiatry 
as an alternative to DSM diagnoses, but its utility for 
other areas of research may be more limited because 
RDoC does not specifically model the observable signs 
and symptoms of mental illness that are the subject of 
most theories of psychopathology. That is, it does not 
include detailed representations of clinical phenotypes 
(e.g., aggression, narcissism, emotional lability) that are 
common targets in research on organizations, close 
relationships, social groups, aging, psychotherapy, and 
many other fields wherein the prevailing theoretical 
models have little (or no) biological emphasis.
A complementary nosological framework is needed 
to link the basic science discoveries spurred by RDoC—
and similar National Institutes of Health initiatives, such 
as the National Institute of Alcohol Abuse and Alcohol-
ism’s Addictions Neuroclinical Assessment and the 
National Institute of Drug Abuse’s Phenotyping Assess-
ments Battery—to the signs and symptoms that lead 
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people to seek treatment. HiTOP, which provides a 
clear and comprehensive system of clinical phenotypes, 
offers such a bridge. Research that integrates these 
dimensional frameworks has the potential to make 
RDoC clinically relevant and to provide important 
insights into the biological bases of the dimensions 
embodied in the HiTOP framework.
Whereas RDoC proponents acknowledge that it is 
unlikely to have much applied clinical value in the near 
term, HiTOP is poised for clinical implementation. 
HiTOP encapsulates clinical problems that practitioners 
are familiar with and routinely encounter. Existing ques-
tionnaire and interview measures that capture HiTOP 
dimensions can be administered to patients or other 
informants (Kotov et  al., 2017). Normative data are 
available for many measures and will continue to accrue 
(e.g., Stasik-O’Brien et  al., 2018). Clinicians can use 
dimensional scores to compare patients’ scores to clini-
cal cutoffs or other norms to inform decisions about 
prognosis and treatment (see Ruggero, 2018). Moreover, 
dimensional measures are more useful for monitoring 
treatment progress than are categorical diagnoses 
because they tend to be more sensitive to change while 
also yielding more reliable change indices (e.g., Kraemer, 
Noda, & O’Hara, 2004). One of the most important chal-
lenges for the future will be to gather appropriate nor-
mative data for more instruments and refine their use 
in clinical assessment and treatment planning.
The hierarchical structure of HiTOP implies that tar-
geting higher order dimensions such as the internal-
izing spectrum may cause therapeutic effects to 
percolate across multiple DSM conditions, augmenting 
the efficiency of psychological treatment. For example, 
the Unified Protocol for Transdiagnostic Treatment of 
Emotional Disorders (Barlow, Sauer-Zavala, Carl, Bullis, 
& Ellard, 2014) was developed to act on common tem-
peramental processes theorized to lie at the core of 
internalizing problems. Rather than using separate pro-
tocols to treat individual diagnoses, such as major 
depression and generalized anxiety disorder, the Uni-
fied Protocol uses cognitive-behavioral strategies to 
reduce negative emotionality and increase positive 
emotionality, traits thought to maintain anxiety and 
depression over time, and emerging evidence shows 
Table 1. Prominent Mental Illness Frameworks
Characteristic DSM HiTOP RDoC
Empirical 
foundation
Historically based on clinical 
heuristics; recent revisions are 
guided by systematic review of 
research evidence
Data-driven; observed clustering 
of psychopathology signs and 
symptoms
Expert workgroup 
interpretation of research 
evidence
Structure Signs and symptoms are organized 
into diagnoses, which are in turn 
grouped into chapters on the 
basis of shared phenomenology 
and/or presumed etiology; some 
disorders include subtypes
Hierarchical system of broad 
constructs near the top and 
homogeneous symptom 
components near the bottom
Five domains of functioning 
(e.g., negative valence) 
each divided into three to 
six constructs (e.g., acute 
threat); domains encompass 
seven units of analysis, from 
molecules to verbal report
Dimensional vs. 
categorical
Predominantly categorical but contains 
optional dimensional elements 
for screening and diagnosis, 
such as the alternative model for 
personality disorder in DSM–5
Dimensional but able to 
incorporate categories (taxa) 
if empirically warranted





Widely used Able to guide assessment and 
treatment but currently not 
disseminated widely for 
direct clinical application
Limited prospects for clinical 
applications in near term 
(e.g., assessment, treatment, 
communication)
Etiology Diagnosis generally is based 
on observed signs and 
symptoms, not putative causes 
(posttraumatic stress disorder is 
an exception)




clinical problems; model 
dimensions can be validated 
with respect to putative 
etiological factors
Conceptualizes clinical 
problems as “brain 
disorders”; neurobiological 
correlates of mental illness 
are emphasized
Note: DSM = Diagnostic and Statistical Manual of Mental Disorders; HiTOP = Hierarchical Taxonomy of Psychopathology; RDoC = Research 
Domain Criteria.
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that such transdiagnostic psychotherapies can be as 
effective as traditional (i.e., diagnosis-specific) treat-
ments (Barlow, Farchione, Bullis, Gallagher, & Cassiello-
Robbins, 2017). Practitioners can apply the Unified 
Protocol to a diverse set of anxiety and depressive 
conditions, streamlining the training process and mini-
mizing barriers to dissemination, compared with stan-
dard training models that involve learning a separate 
treatment framework for each disorder (Steele et  al., 
2018). The policy of using one psychological treatment 
for various conditions is analogous to standard pre-
scription practices for psychiatric medications, which 
often work across—and in many cases have regulatory 
approval for treatment of—multiple diagnoses.
The most important avenue for future empirical 
work, in our view, is continued validation research into 
the utility (for research and theory building) of the 
dimensions that make up the HiTOP model. In particu-
lar, validation studies to date have been mostly limited 
to the spectrum level (e.g., correlates of internalizing, 
disinhibited externalizing), and criterion-validity 
research is needed at other levels of the hierarchy. In 
addition, existing research has largely relied on snap-
shots of symptoms and syndromes without modeling 
illness course. Longitudinal studies that are designed 
to examine the correlates and structure of HiTOP 
dimensions in diverse samples across the life span are 
a pressing priority (cf. Lahey et al., 2015; Wright, Hopwood, 
Skodol, & Morey, 2016), as is research on the short-term 
dynamics of psychopathology symptoms (e.g., Wright 
& Simms, 2016). Although research has supported the 
invariance of the internalizing and externalizing spec-
tra across gender, developmental stages, and various 
racial, ethnic, and cultural groups (see Rodriguez-
Seijas et al., 2015), investigating other HiTOP dimen-
sions with regard to aging, culture, context, and so 
forth will be important.
Conclusion
There is compelling evidence that the nature of psy-
chopathology is dimensional and hierarchical, with 
many studies indicating that genes, neurobiology, and 
clinical outcomes align with this new conceptualization. 
We recommend a shift in mental-health research prac-
tices to match the HiTOP model. This emerging system 
has the potential to (a) expand existing theories and 
generate new hypotheses, (b) unify unnecessarily frag-
mented empirical studies, (c) increase the utility of 
classification systems for both basic and applied 
research, and (d) establish novel phenotypes that 
explain the etiology of psychological problems and 
serve as more efficient assessment and treatment tar-
gets. Although many important challenges remain, 
HiTOP has the potential to transform research practices 
for the better and accelerate theory development across 
diverse areas of psychological science.
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Notes
1. Unlike DSM and ICD workgroups, HiTOP membership has 
developed organically rather than through selection. The con-
sortium was founded by Roman Kotov, Robert Krueger, and 
David Watson, who invited all scientists with significant publi-
cation records on quantitative mental-health nosologies to join 
the consortium. As the consortium grew and gained greater 
recognition, scientists began contacting the consortium offering 
to contribute their effort.
2. We emphasize, however, that it is optimal from a HiTOP per-
spective to orient data collection around more homogeneous 
signs and symptoms of mental disorder (e.g., Markon, 2010; 
Waszczuk, Kotov, et al., 2017).
3. Incidentally, this is roughly the same recruitment strategy 
recommended under the RDoC framework.
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